Displaying 101 - 110 of 754 results for "que le hace el exceso de adrenalina a mi cuerpo"
-
SSI webinar 2: Surveillance
This presentation from webinar 2: surveillance is a fantastic opportunity to learn from two SSI experts about the national SSI programme that all 20 district health boards have signed up to, and how it can help to prevent SSIs.
-
Comparison of the Aotearoa New Zealand Early Warning Score and National Early Warning Score to predict adverse inpatient events in a vital sign dataset
Mohan C, Entezami P, John S, Hewitt J, Sylevych A, Psirides A
Anaesthesia -
Chronic Obstructive Pulmonary Disease in people aged 45 and over
The goal of this Atlas domain is to highlight variation in the prevalence, admissions, and medicine use of people estimated to have Chronic Obstructive Pulmonary Disease (COPD).
- Equity Explorer
-
Harm (adverse) event submission portal
Use this portal to report and manage harm (adverse) events, as part of the Healing, Learning and Improving from Harm policy. You can complete Part A and Part B sections, edit and review, and download your data.
-
Recovering from a hip fracture | Pikinga ora i tētahi whatinga hope (booklet in English and te reo Māori)
The Commission has helped to develop a hip fracture recovery information booklet to meet the needs of the population in Aotearoa New Zealand.
-
Co-designing a patient, family and whānau escalation of care process factsheet for patients, family and whānau (consumers)
The Commission has developed a new co-design resource: a factsheet for hospitals to give to consumers who are considering joining the Kōrero mai/Talk to me co-design team. This was originally published in June 2017 and was updated in October 2020.
-
Atlas domains with primary health organisation analyses
All Atlas of Healthcare Variation domains report variation at the health district level (formerly district health boards). We have also analysed some domains by primary health organisation (PHO).
-
Pharmac leaflet explaining medicine brand changes
This leaflet from Pharmac explains why brand names, appearance and packaging of your medicines may have changed.
-
Zero seclusion case studies: How DHBs are successfully reducing the use of seclusion
This document features the experiences of six health professionals who have successfully reduced the use of seclusion in their district health board's mental health and addiction services.